Aspergillosis and the lung;Aspergillus et poumon

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 44, Issue 1, 2004, Pages 83-88

  Couturaud, F ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergilloma; Invasive pulmonary aspergillosis; Pulmonary aspergillosis; Treatment

Indexed keywords

ANTIFUNGAL AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG TOLERABILITY; HUMAN; IMMUNE SYSTEM; LUNG ASPERGILLOSIS; MICROORGANISM; PATHOPHYSIOLOGY; REVIEW; VIRULENCE;

EID: 0346730050     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(03)00316-2     Document Type: Review

References (48)

1. Raper KB, Fennel DJ. The genus Aspergillus. New York: Ed R.E. Krieger Publishing Company, Huntington; 1973. p. 686.
2. Kawamura S, Maesaki S, Tomono K, et al. Clinical evaluation of 61 patients with pulmonary aspergilloma. Intern Med 2000;39:209-12.
3. Aspergilloma and residual tuberculous cavities: the results a resurvey. Tubercle 1970;51:227-45.
4. Glimp R, Bayer A. Pulmonary aspergilloma: diagnostic and therapeutic considerations. Arch Intern Med 1983;143:303-8.
5. Stevens DA, Kan VL, Judson MA, et al. Practice Guidelines for diseases caused by Aspergillus: Infectious Diseases Society of America. Clin Infect Dis 2000;30:696-709.
6. Roberts CM, Citron KM, Strickland B. Intrathoracic aspergilloma: role of CT in diagnosis and treatment. Radiology 1987;165:123-8.
7. McCarthy DS, Pepys J. Pulmonary aspergilloma: clinical immunology. Clin Allergy 1973;3:57-70.
8. Regnard JF, Icard P, Nicolosi M, et al. Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg 2000;69:898-903.
9. Chen JC, Chang YL, Lu SP, et al. Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax 1997;52:810-3.
10. Arrivée L, Tubiana J. La radiologie interventionnelle dans le traitement des hémoptysies. Presse Médicale 1995;24:910-4.
11. Yamada H, Kohno S, Koga H, Maesaki S, Kaku M. Topical treatment of pulmonary aspergilloma by antifungas: relationship between duration of the disease and efficacy of therapy. Chest 1993;103:1421-5.
12. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Academ Derm 1990;23:607-14.
13. Cockrill BA, Hales CA. Allergic bronchopulmonary aspergillosis. Annu Rev Med 1999;50:303-16.
14. Basich JE, Graves TS, Baz MN, et al. Allergic bronchopulmonary aspergillosis in corticosteroid-dependant asthmatics. J Allergy Clin Immunol 1981;69:98-102.
15. Brueton MJ, Ormerod LP, Shah KJ, et al. Allergic bronchopulmonary aspergillosis complicating cystic fibrosis. Arch Dis Child 1980;55:348-53.
16. Fournier E, Tonnel AB, Wallaert B, et al. L'aspergillose pulmonaire allergique. A propos de 30 observations. Poumon et Cœur 1983;39:75-82.
17. Mintzer RA, Rogers LF, Kruglil GD, et al. The spectrum of radiologic findings in allergic bronchopulmonary aspergillosis. Radiology 1978;127:301-7.
18. Wang JL, Patterson R, Rosenberg M, et al. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978;117:917-27.
19. Greenberger PA, Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy 1986;56:444-8.
20. Patterson R, Greenberger PA, Radin RC, et al. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982;96:286-91.
21. Rosenberg M, Patterson R, Roberts M, et al. The assessement of immunologic and clinical changes occuring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978;64:599-606.
22. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary asprgillosis. N Engl J Med 2000;342:756-62.
23. Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomised controlled trial. J Allergy Clin Immunol 2003;111:952-7.
24. Salvaggio JE. Hypersensitivity pneumonitis. J Allergy Clin Immunol 1987;79:558-71.
25. Katzenstein AL, Liebow AA, Friedmann PJ. Bronchocentric granulomatosis, mucoid impaction and hypersensitivity reaction to fungi. Am Rev Respir Dis 1975;111:497-537.
26. Denning D, Stevens D. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990;12:1147-201.
27. Gerson S, Talbot G, Hurwitzs S, et al. Invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1985;79:57-64.
28. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996;109:1066-77.
29. Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:654-62.
30. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47.
31. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358-66.
32. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropénic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 1999;17:796-805.
33. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-803.
34. Horvarth JA, Dummer S. The use of respiratory tract cultures for the diagnosis of invasive pulmonary aspergillosis. Am J Med 1986;100:171-8.
35. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis 1995;20:598-605.
36. Sulahian A, Tabouret M, Ribaud P, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Infect Dis 1996;15:139-45.
37. Cordonnier C, Bernaudin JF, Fleury J, et al. Diagnostic yield of bronchoalveolar lavage in pneumonitis occuring after allogenic bone marrow transplantation. Am Rev Respir Dis 1985;132:1118-23.
38. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86:518-23.
39. Buchheidt D, Baust C, Skladny H, et al. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples neutropenic patients. Br J Haematol 2002;116:803-11.
40. Ascioglu S, Rex JH, de Pauw, et al. EORTC, NIAIDMSG, NIH. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
41. Gallis H, Drew R, Pickard W. amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12:308-29.
42. Lendeers AC, Daenen S, Jansen RLH, et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol 1998;103:205-12.
43. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole vs amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15.
44. th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology; 2000.
45. Bernard A, Loire J, Caillot D, et al. Résections pulmonaires en urgence pour aspergillose invasive chez des patients neutropéniques. Annales de Chirurgie 1995;49:849-53.
46. Binder RE, Faling LJ, Pugatch RD, et al. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 1982;61:109-24.
47. Caras W, Pluss J. Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy. Mayo Clin Proc 1996;71:25-30.
48. Saraceno JL, Phelps DT, Ferro TJ, et al. Chronic necrotizing aspergillosis: approach to management. Chest 1997;112:541-8.